Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis

CONCLUSIONS: NTRK-fusion positive tumors are rare but detection is improved through RNA sequencing. TRKi could be considered at diagnosis for CNS NTRK-fusion positive tumors, some IFS and Other-MT.TRIAL REGISTRATION: not adapted.PMID:37434345 | DOI:10.1080/14737140.2023.2236305

Source: Expert Review of Anticancer Therapy - July 12, 2023 Category: Cancer & Oncology Authors: Lauriane Lemelle Delphine Guillemot Anne-Laure Hermann Arnaud Gauthier Matthieu Carton Nad ège Corradini Ang élique Rome Pablo Berlanga Anne Jourdain Aude Marie Cardine Sarah Jannier H élène Boutroux Anne Sophie Defachelles Isabelle Aerts Birgit Geoer Source Type: research